Slizgi JR[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2015	1
2016	2
2017	2
2018	1
2020	1
2023	0

Page 1

Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases.

Muehler A, Slizgi JR, Kohlhof H, Groeppel M, Peelen E, Vitt D. Muehler A, et al. Among authors: slizgi jr. World J Gastrointest Pathophysiol. 2020 Dec 12;11(6):114-130. doi: 10.4291/wjgp.v11.i6.114. World J Gastrointest Pathophysiol. 2020. PMID: 33362939 Free PMC article. Review.

Effect of Liver Disease on Hepatic Transporter Expression and Function.

Thakkar N, Slizgi JR, Brouwer KLR. Thakkar N, et al. Among authors: slizgi jr. J Pharm Sci. 2017 Sep;106(9):2282-2294. doi: 10.1016/j.xphs.2017.04.053. Epub 2017 Apr 30. J Pharm Sci. 2017. PMID: 28465155 Free PMC article. Review.

Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease.

Brock WJ, Beaudoin JJ, Slizgi JR, Su M, Jia W, Roth SE, Brouwer KLR. Brock WJ, et al. Among authors: slizgi jr. Int J Toxicol. 2018 Mar/Apr;37(2):144-154. doi: 10.1177/1091581818760746. Int J Toxicol. 2018. PMID: 29587557 Free PMC article.

Hepatocellular Disposition and Transporter Interactions with Tolvaptan and Metabolites in Sandwich-Cultured Human Hepatocytes.

Lu Y, Slizgi JR, Brouwer KR, Claire RL, Freeman KM, Pan M, Brock WJ, Brouwer KL. Lu Y, et al. Among authors: slizgi jr. Drug Metab Dispos. 2016 Jun;44(6):867-70. doi: 10.1124/dmd.115.067629. Epub 2016 Mar 24. Drug Metab Dispos. 2016. PMID: 27013400 Free PMC article.

Transporter-Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate.

Ali I, Slizgi JR, Kaullen JD, Ivanovic M, Niemi M, Stewart PW, Barritt AS 4th, Brouwer KLR. Ali I, et al. Among authors: slizgi jr. Clin Pharmacol Ther. 2017 Dec 22:10.1002/cpt.997. doi: 10.1002/cpt.997. Online ahead of print. Clin Pharmacol Ther. 2017. PMID: 29271075 Free PMC article.

Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?

Slizgi JR, Lu Y, Brouwer KR, St Claire RL, Freeman KM, Pan M, Brock WJ, Brouwer KL. Slizgi JR, et al. Toxicol Sci. 2016 Jan;149(1):237-50. doi: 10.1093/toxsci/kfv231. Epub 2015 Oct 26. Toxicol Sci. 2016. PMID: 26507107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results